Protective effects of intraperitoneal vitamin C, aprotinin and melatonin administration on retinal edema during experimental uveitis in the guinea pig

Cell Biochemistry and Function

Volumn 22, Issue 5, 2004, Pages 299-305

  Kükner, A Şahap ^a   Kükner, Aysel ^a   Naziroǧlu, Mustafa ^b,d   Çolakoǧlu, Neriman ^c   Çelebi, Serdal ^a   Yilmaz, Turgut ^c   Aydemir, Orhan ^c  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c FIRAT UNIVERSITY   (Turkey)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Aprotinin; Experimental uveitis; Melatonin; Retina; Vitamin C

Indexed keywords

ANTIOXIDANT; APROTININ; ASCORBIC ACID; BOVINE SERUM ALBUMIN; FREE RADICAL; MELATONIN; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL MEMBRANE FLUIDITY; CONTROLLED STUDY; GUINEA PIG; HISTOPATHOLOGY; MALE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RETINA EDEMA; RETINA INNER PLEXIFORM LAYER; THICKNESS; UVEITIS;

ANIMALS; ANTIOXIDANTS; APROTININ; ASCORBIC ACID; FREE RADICAL SCAVENGERS; GUINEA PIGS; HISTOCYTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; MALE; MELATONIN; PAPILLEDEMA; RETINA; SERUM ALBUMIN, BOVINE; UVEITIS;

ANIMALIA; BOVINAE; CAVIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 4444353682     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.1105     Document Type: Article

References (27)

1. Rao NA, Guey-Shuang W. Free radical mediated photoreceptor damage in uveitis. Prog Retin Eye Res 2000; 19: 41-68.
2. Saoudi A, Hurez V, De Kozak Y, et al. Human immunoglobulin preparations for intravenous use prevent experimental autoimmune uveoretinitis. Int Immunol 1993; 5: 1559-1567.
3. Vrabec TR, Gregerson DS, Dua HS, Donoso LA. Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides. Autoimmunity 1992; 12: 175-184.
4. Reiter RJ, Tan DX, Manchester LC, Calvo JR. Antioxidant capacity of melatonin. In Handbook of Antioxidants (2nd edn), Cadenas E, Packer L (eds). Marcel Dekker: New York, 2002; 565-614.
5. Sackett CS, Schenning S. The age-related eye disease study: the results of the clinical trial. Insight 2002; 27: 5-7.
6. Wu GS, Walker J, Rao NA. Effect of deferoxamine on retinal lipid peroxidation in experimental uveitis. Invest Ophthalmol Vis Sci 1993; 34: 3084-3089.
7. Ishimoto SL, Wu GS, Hayashi S, Zhang J, Rao NA. Free radical tissue damages in the anterior segment of the eye in experimental autoimmune uveitis. Invest Ophthamol Vis Sci 1996; 37: 630-636.
8. Halliwell B, Gutteridge JM. Protection against radical damage: systems with problems. In Free Radicals in Biology and Medicine, Halliwell B, Gutteridge JM (eds). Clarendon Press: Oxford, UK, 1996; 289-298.
9. Jacob RA, Sotoudeh G. Vitamin C function and status in chronic disease. Nutr Clin Care 2002; 5: 47-49.
10. van Rooij J, Schwartzenberg SC, Mulder PC, Baarsma SC. Oral vitamins C and E as additional treatment in patients with acute anterior uveitis: a randomized double masked study in 145 patients. Br J Ophthalmol 1999; 83: 1277-1282.
11. Koch FH, Augustin AJ, Grus FH, Spitznas M. Effects of different antioxidants on lens-induced uveitis. Cer J Ophthalmol 1996; 5: 185-188.
12. Westaby S. Aprotinin in perspective. Ann Thorac Surg 1993; 55: 1033-1041.
13. Pierrefiche G, Topall G, Courboin G, Henriet I, Laborit H. Antioxidant activity of melatonin in mice. Res Commun Chem Pathol Pharmacol 1993; 80: 211-223.
14. Reiter RJ, Tan D, Sainz RM, Mayo JC, Burillo SL. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol 2002; 54: 1299-1321.
15. Yilmaz T, Çelebi S, Kükner AŞ. The protective éffects of melatonin, vitamin E and octreotide on retinal edema during ischemia-reperfusion in the guinea pig retina. Ear J Ophthalmol 2002; 12: 443-449.
16. Touitou Y, LeHoang P, Claustrat B, et al. Decreased nocturnal plasma melatonin peak in patients with a functional alteration of the retina in relation with uveitis. Neurosci Lett 1986; 70: 170-174.
17. Yamauchi H, Iso T, Iwata H. Ocular anti-inflammatory and systemic immunosuppressive effects of topically applied fluorometholone. Jpn J Pharmacol 1979; 29: 87-92.
18. Mo JS, Matsukawa A, Ohkawara S, Yoshinaga M. Role and regulation of IL-8 and MCP-1 in LPS-induced uveitis in rabbits. Exp Eye Res 1999; 68: 333-340.
19. Perlman JI, Shuber H, Selvaraj RP, Cassidy EM. Free radical generation following pressure-induced retinal ischemia in the rat. Retina 1999; 19: 255-257.
20. Dadoukis J, Angouridakis K, Aletras H. Action of the basic trypsin inhibitor, Trasylol, on shock resulting from occlusion of the superior mesenteric artery. Experimental study. J Int Med Res 1981; 9: 31-38.
21. Wilhelim DL. Pattern and mechanism of increased vascular permeability in inflammation. In The Inflammatory Process, Zweifach BW, Grant L, et al. (eds). Academic Press Inc.: New York, 1973.
22. Sunamori M, Innami R, Amano J, Suzuki A, Harrison CE, Role of protease inhibition in myocardial preservation in prolonged hypotermin cardioplegia followed by reperfusion. J Thorac Cardiovasc Surg 1988; 96: 314-320.
23. Shida CS, Castrucci AML, Lamy-Freund MP. High melatonin solubility in aqueous media. J Pineal Res 1994; 16: 198-201.
24. Costa EJX, Shìda CS, Biaggi MH, Ito AS, Lamy-Freund MP. How melatonin interacts with lipid bilayers: a study by fluorescence and ESR spectroscopies. FEES Lett 1997; 416: 103-106.
25. Jacques PF, Taylor A, Hankinson SE, et al. Long-term vitamin C supplement use and prevalence of early age-related lens opacities. Am J Clin Nutr 1997; 66: 911-916.
26. Weiss SJ. Tissue destruction by neutrophils. N Eng J Med 1989; 320: 365-376.
27. Kökçam I, Naziroǧlu M. Effects of vitamin E supplementation on blood antioxidant levels in patients with Behçet's disease. Clin Biochem 2002; 35: 633-639.